Related Experiment Video
Updated: Aug 16, 2026

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Published on: March 23, 2016
Side effects of antiglaucomatous drugs on the ocular surface
1Department of Ophthalmology, Hopital Ambroise Paré, Boulogne, France.
Abstract:
An increasing number of studies, both experimental and epidemiologic, have shown that filtering glaucoma surgery has progressively become less effective than initially described. Of a number of risk factors for failure, duration and number of antiglaucoma drugs before surgery seem to play a critical role, and high accumulated antiglaucoma topical treatments significantly reduce success rates. Histopathologic studies have confirmed that topically applied drugs may exert toxic effects to the corneoconjunctival surface and induce chronic infraclinical inflammation, as shown by the presence of immunologic changes and inflammatory infiltrates in multitreated eyes. The origin of topical inflammation has not yet been clearly determined, but benzalkonium chloride, which is used as a preservative in almost all antiglaucoma preparations, has shown strong evidence of toxicity to the ocular surface. A number of questions remain to be investigated, but suppression of preservatives from chronically applied drugs should be a critical issue in the near future.
Insights
Filtering glaucoma surgery success decreases with more pre-operative antiglaucoma drugs. Topical treatments may cause ocular surface toxicity and inflammation, impacting surgical outcomes. Preservative-free options are crucial for future treatments.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Ocular Pharmacology
Background:
- Filtering glaucoma surgery effectiveness is declining.
- Pre-operative antiglaucoma drug use is a significant risk factor for surgical failure.
- Topical antiglaucoma medications may cause ocular surface toxicity and inflammation.
Purpose of the Study:
- To investigate the impact of pre-operative antiglaucoma drug exposure on filtering glaucoma surgery outcomes.
- To explore the role of topical drug toxicity and ocular inflammation in surgical failure.
- To highlight the need for preservative-free antiglaucoma formulations.
Main Methods:
- Review of experimental and epidemiological studies.
- Histopathologic examination of ocular tissues from patients with chronic topical treatment.
- Analysis of risk factors associated with reduced surgical success rates.
Main Results:
- Increased duration and number of antiglaucoma drugs significantly reduce surgical success rates.
- Chronic topical treatments induce immunologic changes and inflammatory infiltrates.
- Benzalkonium chloride, a common preservative, shows evidence of ocular surface toxicity.
Conclusions:
- Accumulated topical antiglaucoma treatments negatively affect filtering surgery outcomes.
- Ocular surface inflammation, potentially linked to preservatives like benzalkonium chloride, is a critical factor.
- Future research should focus on preservative-free antiglaucoma drug formulations to improve surgical success.
Related Concept Videos
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Accessory Structures of the Eye
Ophthalmic Drug Delivery Systems

